Home
Events
Jobs
About
Members
Contact Us
Chrysalis BioTherapeutics Granted Orphan Drug Status for TP508
August 21, 2019
by
Website Admin
in
Tweet
Share
Pin it
Previous Story
Bellicum Pharmaceuticals Announces Aggregate Gross Proceeds of $69.6 Million from $139.6 Million Public Offering and Private Placement
Next Story
Nanospectra Biosciences Announces PNAS Publication of Initial Results of First Clinical Trial of Gold Nanoshell-Localized Photothermal Ablation of Prostate Tissue
Top